BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 20561457)

  • 1. [Antioncogene PTEN-a new target for myeloma therapy].
    Wang SY; Cheng ZY; Deng K; Chen H; Pan L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):816-20. PubMed ID: 20561457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [PTEN: a new target in inhibiting of tumor invasion and metastasis].
    Liang WT; Cheng ZY; Jia ZQ; Wang BY
    Sheng Li Ke Xue Jin Zhan; 2011 Jun; 42(3):201-5. PubMed ID: 21932518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
    Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
    Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of PTEN deletions and mutations in multiple myeloma.
    Chang H; Qi XY; Claudio J; Zhuang L; Patterson B; Stewart AK
    Leuk Res; 2006 Mar; 30(3):262-5. PubMed ID: 16112193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of PTEN-FAK signaling pathway in metastasis and invasive ability of leukemia cells].
    Cheng ZY; Guo XL; Li SH; Wang SY; Yang XY; Xue F; Wen SP; Pan L
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):115-20. PubMed ID: 19563023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity.
    Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN
    Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo.
    Ge NL; Rudikoff S
    Oncogene; 2000 Aug; 19(36):4091-5. PubMed ID: 10962569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of Pten in osteo-chondroprogenitor cells leads to epiphyseal growth plate abnormalities and skeletal overgrowth.
    Ford-Hutchinson AF; Ali Z; Lines SE; Hallgrímsson B; Boyd SK; Jirik FR
    J Bone Miner Res; 2007 Aug; 22(8):1245-59. PubMed ID: 17456009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SnapShot: PTEN signaling pathways.
    Carracedo A; Salmena L; Pandolfi PP
    Cell; 2008 May; 133(3):550.e1. PubMed ID: 18455993
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.
    Shi Y; Gera J; Hu L; Hsu JH; Bookstein R; Li W; Lichtenstein A
    Cancer Res; 2002 Sep; 62(17):5027-34. PubMed ID: 12208757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression.
    Zhang LL; Liu J; Lei S; Zhang J; Zhou W; Yu HG
    Cell Signal; 2014 May; 26(5):1011-20. PubMed ID: 24486402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protein phosphatase activity of PTEN is essential for regulating neural stem cell differentiation.
    Lyu J; Yu X; He L; Cheng T; Zhou J; Cheng C; Chen Z; Cheng G; Qiu Z; Zhou W
    Mol Brain; 2015 Apr; 8():26. PubMed ID: 25927309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nuclear affairs of PTEN.
    Planchon SM; Waite KA; Eng C
    J Cell Sci; 2008 Feb; 121(Pt 3):249-53. PubMed ID: 18216329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN regulates phospholipase D and phospholipase C.
    Alvarez-Breckenridge CA; Waite KA; Eng C
    Hum Mol Genet; 2007 May; 16(10):1157-63. PubMed ID: 17405772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
    Fang J; Ding M; Yang L; Liu LZ; Jiang BH
    Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory effects of tumor suppressor gene PTEN on proliferation and metastasis of breast cancer ZR-75-1 cells].
    Lin GP; Li XY; Huang JW; Xiong L; Zhou KY
    Ai Zheng; 2007 Oct; 26(10):1069-73. PubMed ID: 17927875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenets of PTEN tumor suppression.
    Salmena L; Carracedo A; Pandolfi PP
    Cell; 2008 May; 133(3):403-14. PubMed ID: 18455982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of PTEN signaling perturbations in cancer and in targeted therapy.
    Keniry M; Parsons R
    Oncogene; 2008 Sep; 27(41):5477-85. PubMed ID: 18794882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.